A Novel Nanobody Precisely Visualizes Phosphorylated Histone H2AX in Living Cancer Cells under Drug-Induced

Eric Moeglin1, Dominique Desplancq1, Audrey Stoessel1

  • 1Biotechnologie et Signalisation Cellulaire, UMR 7242, CNRS/Université de Strasbourg, Boulevard S. Brant, 67412 Illkirch, France.

Cancers
|July 20, 2021
PubMed

Insights

Researchers developed novel nanobodies to detect phosphorylated H2AX (γ-H2AX), a marker of DNA damage, in living cells. This breakthrough enables real-time monitoring of DNA repair dynamics and drug screening in cancer research.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Phosphorylated H2AX (γ-H2AX) is a critical marker for DNA double-strand breaks and replication stress in mammalian cells.
  • Current methods for γ-H2AX detection are limited to fixed cells, hindering real-time analysis of DNA damage responses.

Purpose of the Study:

  • To develop novel tools for detecting γ-H2AX in living cells.
  • To enable dynamic studies of chromatin modifications and facilitate genotoxic drug screening.

Main Methods:

  • Isolation of γ-H2AX-specific nanobodies using immune libraries and phage display.
  • Crystal structure determination of nanobody-phosphopeptide complex.
  • Engineering of bivalent nanobodies and fluorescent fusion proteins.
  • Development of a transduction strategy for live-cell imaging.

Main Results:

  • Successfully isolated and characterized nanobodies with high specificity for γ-H2AX.
  • Demonstrated quantitative visualization of γ-H2AX in fixed cells using bivalent nanobodies.
  • Achieved sensitive detection of γ-H2AX foci in intact living cells using fluorescent nanobody fusion proteins.

Conclusions:

  • Developed a novel nanobody-based tool for sensitive and precise detection of γ-H2AX in both fixed and living cells.
  • This tool facilitates rapid screening of genotoxic drugs and allows in-depth study of DNA damage dynamics in individual cells.

Related Concept Videos